Anphabe

Connecting opportunities
hZWXmpZlknKZl5uExaBkb-GkoGOYcFLJpMWoq4DHo5ifmatXc6xsmWJrUr98qKellJ--oJvSpZbWnaeg0dPXytrJvrPJntaFxd3bz9PHlXbJpc-h1Fhr2XKcb1qe26OXp52oo1p0pZ9hYmqFqJ-Vqailx3-f0ptZn6tuZpyH1MLWxc_ZhmvCc5Sd3eDh

AbbVie

We focus on ground-breaking medicines to address chronic progressive diseases, the most widespread and debilitating diseases, chronic disabling neurological conditions and impairments.

  • hZWXmpZlknKZl5uExaBkb-GkoGOYcFLJpMWoq4DHo5ifmatXc6xsl2lrUr98qKellJ--lqXRoJjSsZBz0dLUwtLdqsvQoMarhp7VnZygU5vbn8mmz6WeiHPXb2lwoFeglK6ygaealrikkqTMq6qbmKZVnaZwmmpZ1Jmmkc_YhpzFnpOg36ObapSdhMbT06GW1KrFm8pYa89ylW1qapdtb7Cx

Company Menu

Why AbbVie?

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases... see more


Inside review about AbbVie

0.0
0 reviews
0%
employees recommend this company to friends
Lazy Load...